NYSE : PRGO

Perrigo Company plc

$12.84 USD

$0.3 (2.39%)

Volume
2.11M
Average Volume
3.22M
Market Capitalization
$1.78B
P/E Ratio
-1.03
Dividend Yield
9.03%
Price Target
$36.00
Year High
$24.61
Year Low
$9.23
Day High
—
Day Low
—
Payout Ratio
-$0.12
Current Ratio
$2.32
Company Overview

NYSE

Albert A. Manzone

Drug Manufacturers - Specialty & Generic

Healthcare

PRGO

8100

IE

USD

https://www.perrigo.com

353 1 709 4000

N/A

0001585364

Liquidity Metrics

1.31

2.32

1.32

0.38

-0.12

Sales & Valuation

$4.25B

0.43

0.71

10.15

1.26

Profitability

-$10.29

-$1.43B

-41.85%

-38.90%

-55.97%

-22.80%

P/E Metrics

-1.03

0.00

0.00

Analyst Price Target & Rating

$36.00

$54.00

$20.00

Sell

2/5

36 Analysts

-64.33%

Financial Health Scores

-0.40

5/9

$1.4B

$7.61B

$5.09B

-$1.45B

Key Metrics (TTM)

$4.63B

1.12

-3.78

2.32

-55.97%

3.27%

-99.45%

10.09%

155 days

Company Executives
Name Title
Eric S. Jacobson Vice President of Global Investor Relations
Robert Willis Chief Human Resources Officer & Executive Vice President
Abbie Lennox Executive Vice President & Chief Scientific Officer
David Ball EVP and Chief Brand & Digital Officer
Albert Ange Manzone Interim President, Interim CEO & Director
Eduardo Guarita Bezerra Executive Vice President & Chief Financial Officer
Matthew Winterman Executive Vice President of Product Supply, Operations Strategy & Transformation Officer
Sonia Hollies Senior VP & Treasurer
Charles Atkinson Executive Vice President, General Counsel & Secretary
Patrick Lockwood-Taylor President, Chief Executive Officer & Director
Roberto Khoury Executive Vice President & Chief Commercial Officer
Poll Results

No votes yet today — be the first to share your view!

About Perrigo Company plc (NYSE:PRGO) Stock

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessatio ... n and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Stock Rises 23% as Q2 Earnings & Sales Beat Estimates

2026-08-06 15:56:28

PRGO tops Q2 EPS estimates as Infant Formula sales jump, helping offset softer demand and divestiture impacts while the company reaffirms 2026 guidance.

Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript

2026-08-05 14:00:10

Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript

Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say

2026-08-05 10:31:20

The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Perrigo (PRGO) Surpasses Q2 Earnings and Revenue Estimates

2026-08-05 08:46:13

Perrigo (PRGO) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.57 per share a year ago.

Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations

2026-08-05 06:30:00

Execution of Three-S plan driving continued improvement in underlying business fundamentals, including market share growth in U.S. store-brand OTC and key European brands Streamlined portfolio through completion of Dermacosmetics divestiture and continuing strategic reviews of Infant Formula and Oral Care businesses Reaffirmed full-year 2026 outlook with sequentially stronger second-half performance  DUBLIN, Aug. 5, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the second quarter ended June 27, 2026. "We continued to execute our Three-S plan in the second quarter, strengthening areas of the business within our control, improving operational performance, streamlining our portfolio, and further reducing debt," said Albert Manzone, Interim President and Chief Executive Officer.

Perrigo Announces Quarterly Dividend

2026-07-30 08:30:00

DUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on September 15, 2026, to shareholders of record on August 28, 2026.

Perrigo to Present at the Canaccord 46th Annual Growth Conference

2026-07-29 08:30:00

DUBLIN, July 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT.  The webcast can be accessed on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026

2026-07-22 08:30:00

DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its second quarter 2026 financial results on Wednesday, August 5th, 2026. The company will hold a conference call beginning at 8:30 a.m.

Frequently Asked Questions

What is the current Perrigo Company plc (PRGO) stock price?

Perrigo Company plc(NYSE:PRGO) stock price is $12.84 in the last trading session. During the trading session, PRGO stock reached the peak price of $24.61 while $9.23 was the lowest point it dropped to. The percentage change in PRGO stock occurred in the recent session was 2.39% while the dollar amount for the price change in PRGO stock was $0.3.

PRGO's industry and sector of operation?

The NYSE listed PRGO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of PRGO?

Eric S. Jacobson | Vice President of Global Investor Relations
Robert Willis | Chief Human Resources Officer & Executive Vice President
Abbie Lennox | Executive Vice President & Chief Scientific Officer
David Ball | EVP and Chief Brand & Digital Officer
Albert Ange Manzone | Interim President, Interim CEO & Director

How many employees does PRGO have?

Number of PRGO employees currently stands at 8100. PRGO operates from The Sharp Building, Dublin, DU D02 TY74, IE.

Link for PRGO official website?

Official Website of PRGO is: https://www.perrigo.com

How do I contact PRGO?

PRGO could be contacted at phone #353 1 709 4000 and can also be accessed through its website. PRGO operates from The Sharp Building, Dublin, DU D02 TY74, IE.

How many shares of PRGO are traded daily?

The average number of PRGO shares traded daily for last 3 months was 3.22M.

What is the market cap of PRGO currently?

The market value of PRGO currently stands at $1.78B with its latest stock price at $12.84